VALUE IN HEALTH

VALUE IN HEALTH(英文缩写 VALUE HEALTH),ISSN 1098-3015,eISSN 1524-4733 是一本学术期刊。本页汇总该期刊的最新影响因子、分区信息以及最新收录于 PubMed 的文献,帮助您快速了解期刊全貌。

2026 年数据 · 影响因子
6.200
JCR 分区
Q1
CAS 分区
B2
近一年发文量
0

指标来源:jcr_cas_ifqb

ISSN: 1098-3015 · eISSN: 1524-4733 · 缩写: VALUE HEALTH

期刊简介

暂无简介。

历年影响因子趋势

年份影响因子JCR 分区
-Q1
-Q1
-Q1
-Q1
-Q1

VALUE IN HEALTH 最新收录文献

  1. Prevalence-based economic evaluation.

    Researchers have often stated that economic evaluations of new drugs have rarely been used to inform healthcare decisions, despite the large volume of published studies. In this paper, a new categoriz…

    查看详情 DOI
  2. From research into practice: how should healthcare organizations/governments decide about lipid therapy and who will pay? Reactor panel and open forum.
    查看详情 DOI
  3. Employer and consumer perspectives.

    This paper reviews various published reports from surveys on employer opinion, perception of needs, and trends with regard to healthcare benefits; the consumer perspective regarding healthcare is also…

    查看详情 DOI
  4. A pharmacy benefit manager perspective.

    Lipid-lowering therapy can account for 7% of per patient per month drug costs. Because this can be a significant proportion of a payer's drug expenditure, this class of drugs attracts payers' attentio…

    查看详情 DOI
  5. A managed care perspective.

    This paper highlights some of the problems associated with lipid therapy in the primary and secondary prevention of cardiovascular disorders and to make some potentially useful suggestions in the cont…

    查看详情 DOI
  6. A US military perspective.

    This paper discusses lipid therapy decision-making at the population level within the United States (US) Military Health Services System. The US Military Health Services System serves approximately 8.…

    查看详情 DOI
  7. A UK Perspective.

    Making decisions on lipid-lowering treatment varies across Europe. Legislation differs from country to country, so it is difficult to generalize about European policy. From the perspective of the Unit…

    查看详情 DOI
  8. A Canadian perspective.

    Although the healthcare program in Canada is in many ways universal, there are several differences between the provinces. Two key federal bodies (the Health Protection Branch of Health Canada and the …

    查看详情 DOI
  9. Commentary on Langley and McKenney Papers.
    查看详情 DOI
  10. Patient education and compliance: how to make it cost-effective.

    The current level of noncompliance with prescription medications exerts a tremendous burden on the healthcare system in terms of both cost and poor health. The process of developing a program to impro…

    查看详情 DOI

在 VALUE IN HEALTH 中搜索更多文献

支持中英文检索 · 智能翻译 · 影响因子 · PDF 下载 · AI 文献阅读

指标接近的期刊